Navigation Links
Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/5/2011

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced its financial results for the quarter ended March 31, 2011.

Optimer reported net income for the first quarter of 2011 of $45.1 million, or $1.06 and $1.04 per basic and diluted share, respectively, as compared to a net loss for the first quarter of 2010 of $13.5 million, or ($0.39) per share on both a basic and diluted basis.  The increase in net income was primarily due to licensing revenue from a $69.2 million upfront payment received from Astellas Pharma in connection with the DIFICID™ collaboration and license agreement. The increase was partially offset by a $10.4 million increase in operating expenses, including $4.3 million in licensing costs due to a royalty payment to Par Pharmaceutical associated with the Astellas upfront payment.

In addition, marketing expenses for the first quarter of 2011 increased $3.2 million compared to the prior year period due to market research and pre-commercialization efforts related to the DIFICID program.  General and administrative expenses increased $5.9 million compared to the first quarter of 2010 due to increases in consulting expenses and advisory fees related to DIFICID collaborations, increases in compensation expense, including a $1.0 million increase in stock compensation expense, and increased headcount, including the establishment of a market access team.  Research and development expenses decreased $2.9 million compared to the first quarter of 2010 due to a $5.0 million milestone payment in the prior year due to Par for the successful completion of the second DIFICID Phase 3 trial offset by an increase in medical affairs and publication expenses.

As of March 31, 2011, Optimer held cash, cash equivalents and short-term investments of $180.1 million.

"Optimer was extremely productive i
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Optimer Pharmaceuticals Expands Senior Management Team
2. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
3. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
4. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
5. Trading Halted Today in Optimer Pharmaceuticals Stock
6. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
7. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
8. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
9. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
10. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
11. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015   ICD-10 Charts ( www.icd10charts.com ... development, it has officially launched its newest line ... Academy and the new 4 Step ICD-10 Implementation ... all other ICD-10 Charts resources and mobile apps, ... completely free-of-charge.  With the release of these resources, ...
(Date:7/7/2015)... July 7, 2015  Shareholder rights law firm ... federal securities fraud class action complaint was filed ... District of California.  The complaint alleges that officers ... ) violated the Securities Exchange Act of 1934 ... by making materially false and misleading statements about ...
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/25648k/elemental ... "Elemental Analysis Market by Type (Organic, Inorganic), Technology ... Sciences, Food and Beverage Testing, Environment Testing) - ... to their offering. The global market ... and applications. By type, the market is categorized ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 2Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 3Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2
... 24, 2011 Codexis, Inc. (Nasdaq: ... launch, its Codex® Screening Kits are in use ... pharmaceutical companies worldwide.  The announcement was made at ... here this week.   Codex® Screening ...
... Oct. 24, 2011 Prometheus Laboratories Inc., a ... commercial launch of its proprietary PROMETHEUS® IBD sgi ... Prometheus, 4th-generation IBD diagnostic test and the first ... inflammation markers, hence "sgi", in the proprietary Smart ...
Cached Medicine Technology:50 Pharma Companies Worldwide Now Use Codexis In Process Development 2Prometheus Launches Next Generation IBD Diagnostic Test 2
(Date:7/7/2015)... ... July 07, 2015 , ... Owners of Green Ladies Cleaning are very pleased ... service category. This honor can only be gained by votes from Madison Magazine readership. ... the products and methods they use daily. Having a home cleaned with all-natural products ...
(Date:7/7/2015)... ... July 07, 2015 , ... More than ... Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy Association's ... $100,000, to help support children fighting muscular dystrophy and related life-threatening diseases ...
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed to ... days at work is knowing that there is hopefully a vacation to look forward ... as imagined. Planning for a vacation can be quite stressful, and it’s difficult sometimes ...
(Date:7/7/2015)... ... ... Down is a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group ... the Toyota Stadium. , The 2015 CONCACAF Gold Cup is now upon us as ... on American soil, will kick off in Frisco, CA from the Toyota Stadium and will ...
Breaking Medicine News(10 mins):Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3
... new study by the NYU Cancer Institute, an NCI-designated ... leukemia, a type of blood cancer that affects children ... an intracellular communication pathway called Notch led to the ... this disease. Notch has already been implicated in another ...
... nine-years-old can start to show an increased risk of future heart ... the May issue of Acta Paediatrica . ... studied 223 children 123 boys and 100 girls with ... over four days. They found that the children who were ...
... appears to have a genetic basis, at least in part. ... small reins) plays a key role in this process, as ... Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now shown. ... to nicotine ( Neuron , May,12, 2011, Vol. 70, Issue ...
... 12 (HealthDay News) -- Music hath charms to protect the ... Northwestern University researchers who compared adults aged 45 to 65 ... to confer advantages in at least two important functions known ... hear speech in noise," study co-author Nina Kraus, director of ...
... at the edge of an ice hole, an Antarctic emperor ... the bird descends and may not emerge again for another ... stores the blood, lungs and myoglobin in muscle ... the surface, lactate begins appearing in the penguin,s blood and ...
... a smoker,s chance of quitting, according to new research published ... This study is the first to assess the effectiveness of ... The research, which was carried out by scientists at the ... enrolled in a programme to help them quit smoking. ...
Cached Medicine News:Health News:Study reveals origins of a cancer affecting the blood and bone marrow 2Health News:Lack of exercise linked to higher heart disease risk in healthy children as young as 9 2Health News:Reining in nicotine use 2Health News:Musicians Maintain Memory, Hearing as They Age 2Health News:Penguins continue diving long after muscles run out of oxygen 2Health News:Penguins continue diving long after muscles run out of oxygen 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: